1. Home
  2. KNSA vs TGI Comparison

KNSA vs TGI Comparison

Compare KNSA & TGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • TGI
  • Stock Information
  • Founded
  • KNSA 2015
  • TGI 1993
  • Country
  • KNSA United Kingdom
  • TGI United States
  • Employees
  • KNSA N/A
  • TGI N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • TGI Aerospace
  • Sector
  • KNSA Health Care
  • TGI Industrials
  • Exchange
  • KNSA Nasdaq
  • TGI Nasdaq
  • Market Cap
  • KNSA 2.1B
  • TGI 2.0B
  • IPO Year
  • KNSA 2018
  • TGI 1996
  • Fundamental
  • Price
  • KNSA $27.53
  • TGI $25.73
  • Analyst Decision
  • KNSA Strong Buy
  • TGI Hold
  • Analyst Count
  • KNSA 5
  • TGI 8
  • Target Price
  • KNSA $38.80
  • TGI $20.63
  • AVG Volume (30 Days)
  • KNSA 1.1M
  • TGI 2.0M
  • Earning Date
  • KNSA 07-22-2025
  • TGI 08-06-2025
  • Dividend Yield
  • KNSA N/A
  • TGI N/A
  • EPS Growth
  • KNSA N/A
  • TGI N/A
  • EPS
  • KNSA N/A
  • TGI 0.52
  • Revenue
  • KNSA $481,166,000.00
  • TGI $1,261,962,000.00
  • Revenue This Year
  • KNSA $37.21
  • TGI $9.20
  • Revenue Next Year
  • KNSA $5.32
  • TGI $6.89
  • P/E Ratio
  • KNSA N/A
  • TGI $49.08
  • Revenue Growth
  • KNSA 59.45
  • TGI 5.87
  • 52 Week Low
  • KNSA $17.38
  • TGI $11.01
  • 52 Week High
  • KNSA $30.69
  • TGI $25.98
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 54.29
  • TGI 50.22
  • Support Level
  • KNSA $27.62
  • TGI $25.68
  • Resistance Level
  • KNSA $29.23
  • TGI $25.85
  • Average True Range (ATR)
  • KNSA 1.03
  • TGI 0.10
  • MACD
  • KNSA -0.21
  • TGI -0.03
  • Stochastic Oscillator
  • KNSA 46.99
  • TGI 19.64

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About TGI Triumph Group Inc.

Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.

Share on Social Networks: